Search research articles
Contact Us
Filters
Showing results (11-20 of 232) with videos related to
Page
of 24
Sort By:
Survey of Ophthalmology
|
July 11, 2003
Possible role for memantine in protecting retinal ganglion cells from glaucomatous damage
Stuart A Lipton
Current Drug Targets
|
May 17, 2007
Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation
Stuart A Lipton
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics
|
February 18, 2005
Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults
Stuart A Lipton
Neuron
|
April 8, 2006
NMDA receptors, glial cells, and clinical medicine
Stuart A Lipton
Nature Reviews. Neuroscience
|
September 21, 2007
Pathologically activated therapeutics for neuroprotection
Stuart A Lipton
Trends in Neurosciences
|
December 2, 2006
Redox regulation of neuronal survival mediated by electrophilic compounds
Takumi Satoh, Stuart A Lipton
Antioxidants & Redox Signaling
|
June 5, 2012
Emerging role of protein-protein transnitrosylation in cell signaling pathways
Tomohiro Nakamura, Stuart A Lipton
Progress in Brain Research
|
October 22, 2008
Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma
Masaaki Seki, Stuart A Lipton
Antioxidants & Redox Signaling
|
October 27, 2007
Emerging roles of S-nitrosylation in protein misfolding and neurodegenerative diseases
Tomohiro Nakamura, Stuart A Lipton
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
November 28, 2007
Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS
Marcus Kaul, Stuart A Lipton
Page
of 24
Search research articles
Search
Showing results (11-20 of 232) with videos related to
Sort By:
Page
of 24
Survey of Ophthalmology
|
July 11, 2003
Possible role for memantine in protecting retinal ganglion cells from glaucomatous damage
Stuart A Lipton
Current Drug Targets
|
May 17, 2007
Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation
Stuart A Lipton
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics
|
February 18, 2005
Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults
Stuart A Lipton
Neuron
|
April 8, 2006
NMDA receptors, glial cells, and clinical medicine
Stuart A Lipton
Nature Reviews. Neuroscience
|
September 21, 2007
Pathologically activated therapeutics for neuroprotection
Stuart A Lipton
Trends in Neurosciences
|
December 2, 2006
Redox regulation of neuronal survival mediated by electrophilic compounds
Takumi Satoh, Stuart A Lipton
Antioxidants & Redox Signaling
|
June 5, 2012
Emerging role of protein-protein transnitrosylation in cell signaling pathways
Tomohiro Nakamura, Stuart A Lipton
Progress in Brain Research
|
October 22, 2008
Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma
Masaaki Seki, Stuart A Lipton
Antioxidants & Redox Signaling
|
October 27, 2007
Emerging roles of S-nitrosylation in protein misfolding and neurodegenerative diseases
Tomohiro Nakamura, Stuart A Lipton
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
November 28, 2007
Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS
Marcus Kaul, Stuart A Lipton
Page
of 24